NO RESPONSE TO RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE I

By Tamary Hannah   Tiqva Petah   Shalev Hanna   Pinsk Vered   Sheva Beer   Zoldan Meira   Zaizov Rina   Tiqva Petah  

Pediatric Hematology and Oncology, Vol. 16, Iss. 2, 1999-03 ,pp. : 165-168

Informa Healthcare

Access to resources Recommend Favorite

SUCCESSFUL TREATMENT OF NEONATAL RHESUS HEMOLYTIC ANEMIA WITH HIGH DOSES OF RECOMBINANT HUMAN ERYTHROPOIETIN

By Wacker Pierre   Ozsahin Hulya   Stelling Maire-José   Humbert James  

Pediatric Hematology and Oncology, Vol. 18, Iss. 4, 2001-06 ,pp. : 279-282

Informa Healthcare

Access to resources Recommend Favorite

The Effectiveness of Recombinant Human Erythropoietin (EPO) Treatment in a Neonate with Hyporegenerative Anemia Following Rh Isoimmunization in Spite of Normal Serum Epo Level

By Erduran Erol   Bahadir Aysenur  

Pediatric Hematology and Oncology, Vol. 28, Iss. 8, 2011-10 ,pp. : 721-722

Informa Healthcare

Access to resources Recommend Favorite

Endothelin Concentrations in Preterm Infants Treated with Human Recombinant Erythropoietin

By  

Neonatology, Vol. 77, Iss. 2, 2000-02 ,pp. : 105-108

Karger

Access to resources Recommend Favorite

The Effect of Recombinant Human Growth Hormone Therapy on Left-Ventricular Chamber Size and Function in Children With Growth Hormone Deficiency

By Esen Ihsan   Cetin Ilker   Demirel Fatma   Ekici Filiz  

Pediatric Cardiology, Vol. 34, Iss. 8, 2013-12 ,pp. : 1854-1859

Springer Publishing Company

Access to resources Recommend Favorite